Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 26, Issue 20
15 October 2020
Issue Cover
All Issues
  • Cover Image

    Cover Image

    issue cover
    This cover shows a multiplex fluorescence image visualized using the Ultivue Ultimapper PD-L1 kit with colors as follows: blue, nuclei; red, PD-L1; yellow, CD68 cells; and green, cytokeratin. Quantification of these images showed PD-L1 in the CD68 compartment is associated with response to durvalumab with chemotherapy in the neoadjuvant setting. For details, see the article by Ahmed and colleagues on page 5456 of this issue.
  • PDF Icon PDF LinkTable of Contents
  • PDF Icon PDF LinkEditorial Board
ISSN 1078-0432
EISSN 1557-3265

Highlights

Selected Articles from This Issue
View articletitled, Selected Articles from This Issue
Open the PDF for in another window

CCR Translations

Moving Beyond BRCA—Incorporating Molecular Assays into Ovarian Cancer Trials
Michelle McMullen; Katherine Karakasis; Amit M. Oza
View articletitled, Moving Beyond BRCA—Incorporating Molecular Assays into Ovarian Cancer Trials
Open the PDF for in another window
TIGIT Blockade and IL15 in Tumor Immunotherapy: Together is Better
Gabriella Pietra; Maria Cristina Mingari; Lorenzo Moretta
View articletitled, TIGIT Blockade and IL15 in Tumor Immunotherapy: Together is Better
Open the PDF for in another window

Reviews

Mouse Models of Oncoimmunology in Hepatocellular Carcinoma
Erin Bresnahan; Katherine E. Lindblad; Marina Ruiz de Galarreta; Amaia Lujambio
View articletitled, Mouse Models of Oncoimmunology in Hepatocellular Carcinoma
Open the PDF for in another window
PD-1 Inhibitors: Do they have a Future in the Treatment of Glioblastoma?
Mustafa Khasraw; David A. Reardon; Michael Weller; John H. Sampson
View articletitled, PD-1 Inhibitors: Do they have a Future in the Treatment of Glioblastoma?
Open the PDF for in another window

Perspectives

Once, Twice, Three Times a Finding: Reproducibility of Dendritic Cell Vaccine Trials Targeting Cytomegalovirus in Glioblastoma
Kristen A. Batich; Duane A. Mitchell; Patrick Healy; James E. Herndon, II; John H. Sampson
View articletitled, Once, Twice, Three Times a Finding: Reproducibility of Dendritic Cell Vaccine Trials Targeting Cytomegalovirus in Glioblastoma
Open the PDF for in another window
Author Choice
Acute Myeloid Leukemia and Myelodysplastic Syndromes with TP53 Aberrations — A Distinct Stem Cell Disorder
Heinz Sill; Armin Zebisch; Detlef Haase
View articletitled, Acute Myeloid Leukemia and Myelodysplastic Syndromes with <em>TP53</em> Aberrations — A Distinct Stem Cell Disorder
Open the PDF for in another window

Clinical Trials: Targeted Therapy

Author Choice
A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor–Positive Breast Cancer
Sara M. Tolaney; Solmaz Sahebjam; Emilie Le Rhun; Thomas Bachelot; Peter Kabos; Ahmad Awada; Denise Yardley; Arlene Chan; Pierfranco Conte; Véronique Diéras; Nancy U. Lin; Melissa Bear; Sonya C. Chapman; Zhengyu Yang; Yanyun Chen; Carey K. Anders
View articletitled, A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor–Positive Breast Cancer
Supplementary data
Open the PDF for in another window
Integration of Antiangiogenic Therapy with Cisplatin and Gemcitabine Chemotherapy in Patients with Nasopharyngeal Carcinoma
Wan Qin Chong; Chwee Ming Lim; Arvind Kumar Sinha; Chee Seng Tan; Gloria Hui Jia Chan; Yiqing Huang; Nesaretnam Barr Kumarakulasinghe; Raghav Sundar; Anand D. Jeyasekharan; Woei Shyang Loh; Joshua K. Tay; Kritika Yadav; Lingzhi Wang; Andrea L. Wong; Li Ren Kong; Ross Andrew Soo; Jieying Amelia Lau; Yu Yang Soon; Robby Miguel Goh; Francis Cho Hao Ho; Siew Meng Chong; Soo Chin Lee; Kwok Seng Loh; Bee Choo Tai; Yaw Chyn Lim; Boon Cher Goh
View articletitled, Integration of Antiangiogenic Therapy with Cisplatin and Gemcitabine Chemotherapy in Patients with Nasopharyngeal Carcinoma
Supplementary data
Open the PDF for in another window
Phase I and Pharmacokinetic Study of Romidepsin in Patients with Cancer and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group Study
Roisin M. Connolly; Eric Laille; Ulka Vaishampayan; Vincent Chung; Karen Kelly; Afshin Dowlati; Olatunji B. Alese; R. Donald Harvey; Paul Haluska; Lillian L. Siu; Shivaani Kummar; Richard Piekarz; S. Percy Ivy; Nicole M. Anders; Melinda Downs; Ashley O'Connor; Angela Scardina; Jacqueline Saunders; Gary L. Rosner; Michael A. Carducci; Michelle A. Rudek; for the ETCTN-9008 Study Team
View articletitled, Phase I and Pharmacokinetic Study of Romidepsin in Patients with Cancer and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group Study
Open the PDF for in another window
A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer
Rahul R. Aggarwal; Michael T. Schweizer; David M. Nanus; Allan J. Pantuck; Elisabeth I. Heath; Eric Campeau; Sarah Attwell; Karen Norek; Margo Snyder; Lisa Bauman; Sanjay Lakhotia; Felix Y. Feng; Eric J. Small; Wassim Abida; Joshi J. Alumkal
View articletitled, A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer
Supplementary data
Open the PDF for in another window
Phase Ib Study of Wnt Inhibitor Ipafricept with Gemcitabine and nab-paclitaxel in Patients with Previously Untreated Stage IV Pancreatic Cancer
Efrat Dotan; Dana B. Cardin; Heinz-Josef Lenz; Wells Messersmith; Bert O'Neil; Steven J. Cohen; Crystal S. Denlinger; Safi Shahda; Igor Astsaturov; Ann M. Kapoun; Rainer K. Brachmann; Shailaja Uttamsingh; Robert J. Stagg; Colin Weekes
View articletitled, Phase Ib Study of Wnt Inhibitor Ipafricept with Gemcitabine and nab-paclitaxel in Patients with Previously Untreated Stage IV Pancreatic Cancer
Open the PDF for in another window

Clinical Trials: Immunotherapy

Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors
Bonnie S. Glisson; Rom S. Leidner; Robert L. Ferris; John Powderly; Naiyer A. Rizvi; Bhumsuk Keam; Reva Schneider; Sanjay Goel; James P. Ohr; Jennifer Burton; Yanan Zheng; Steven Eck; Matthew Gribbin; Katie Streicher; Danielle M. Townsley; Sandip Pravin Patel
View articletitled, Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors
Supplementary data
Open the PDF for in another window
Author Choice
Targeted Natural Killer Cell–Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical Trial
Gabriele Multhoff; Sophie Seier; Stefan Stangl; Wolfgang Sievert; Maxim Shevtsov; Caroline Werner; A. Graham Pockley; Christiane Blankenstein; Martin Hildebrandt; Robert Offner; Norbert Ahrens; Konrad Kokowski; Matthias Hautmann; Claus Rödel; Rainer Fietkau; Dorota Lubgan; Rudolf Huber; Hubert Hautmann; Thomas Duell; Michael Molls; Hanno Specht; Bernhard Haller; Michal Devecka; Andreas Sauter; Stephanie E. Combs
View articletitled, Targeted Natural Killer Cell–Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical Trial
Supplementary data
Open the PDF for in another window

Precision Medicine and Imaging

Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-glutamate (18F-FSPG) for PET/CT Imaging in Patients with Newly Diagnosed and Recurrent Prostate Cancer
Sonya Youngju Park; Sae Jung Na; Meena Kumar; Camila Mosci; Mirwais Wardak; Norman Koglin; Santiago Bullich; Andre Mueller; Mathias Berndt; Andrew W. Stephens; Yong Mee Cho; Hanjong Ahn; Sun Young Chae; Hye Ok Kim; Dae Hyuk Moon; Sanjiv S. Gambhir; Erik S. Mittra
View articletitled, Clinical Evaluation of (4S)-4-(3-[<sup>18</sup>F]Fluoropropyl)-L-glutamate (<sup>18</sup>F-FSPG) for PET/CT Imaging in Patients with Newly Diagnosed and Recurrent Prostate Cancer
Open the PDF for in another window
Diffusion Histology Imaging Combining Diffusion Basis Spectrum Imaging (DBSI) and Machine Learning Improves Detection and Classification of Glioblastoma Pathology
Zezhong Ye; Richard L. Price; Xiran Liu; Joshua Lin; Qingsong Yang; Peng Sun; Anthony T. Wu; Liang Wang; Rowland H. Han; Chunyu Song; Ruimeng Yang; Sam E. Gary; Diane D. Mao; Michael Wallendorf; Jian L. Campian; Jr-Shin Li; Sonika Dahiya; Albert H. Kim; Sheng-Kwei Song
View articletitled, Diffusion Histology Imaging Combining Diffusion Basis Spectrum Imaging (DBSI) and Machine Learning Improves Detection and Classification of Glioblastoma Pathology
Supplementary data
Open the PDF for in another window
Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma
Pauline Krämer; Aline Talhouk; Mary Anne Brett; Derek S. Chiu; Evan S. Cairns; Daniëlla A. Scheunhage; Rory F.L. Hammond; David Farnell; Tayyebeh M. Nazeran; Marcel Grube; Zhouchunyang Xia; Janine Senz; Samuel Leung; Lukas Feil; Jana Pasternak; Katherine Dixon; Andreas Hartkopf; Bernhard Krämer; Sara Brucker; Florian Heitz; Andreas du Bois; Philipp Harter; Felix K.F. Kommoss; Hans-Peter Sinn; Sabine Heublein; Friedrich Kommoss; Hans-Walter Vollert; Ranjit Manchanda; Cornelis D. de Kroon; Hans W. Nijman; Marco de Bruyn; Emily F. Thompson; Ali Bashashati; Jessica N. McAlpine; Naveena Singh; Anna V. Tinker; Annette Staebler; Tjalling Bosse; Stefan Kommoss; Martin Köbel; Michael S. Anglesio
View articletitled, Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma
Supplementary data
Open the PDF for in another window
Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)
Aline Talhouk; Joshy George; Chen Wang; Timothy Budden; Tuan Zea Tan; Derek S. Chiu; Stefan Kommoss; Huei San Leong; Stephanie Chen; Maria P. Intermaggio; Blake Gilks; Tayyebeh M. Nazeran; Mila Volchek; Wafaa Elatre; Rex C. Bentley; Janine Senz; Amy Lum; Veronica Chow; Hanwei Sudderuddin; Robertson Mackenzie; Samuel C.Y. Leong; Geyi Liu; Dustin Johnson; Billy Chen; AOCS Group; Jennifer Alsop; Susana N. Banerjee; Sabine Behrens; Clara Bodelon; Alison H. Brand; Louise Brinton; Michael E. Carney; Yoke-Eng Chiew; Kara L. Cushing-Haugen; Cezary Cybulski; Darren Ennis; Sian Fereday; Renée T. Fortner; Jesús García-Donas; Aleksandra Gentry-Maharaj; Rosalind Glasspool; Teodora Goranova; Casey S. Greene; Paul Haluska; Holly R. Harris; Joy Hendley; Brenda Y. Hernandez; Esther Herpel; Mercedes Jimenez-Linan; Chloe Karpinskyj; Scott H. Kaufmann; Gary L. Keeney; Catherine J. Kennedy; Martin Köbel; Jennifer M. Koziak; Melissa C. Larson; Jenny Lester; Liz-Anne Lewsley; Jolanta Lissowska; Jan Lubiński; Hugh Luk; Geoff Macintyre; Sven Mahner; Iain A. McNeish; Janusz Menkiszak; Nikilyn Nevins; Ana Osorio; Oleg Oszurek; José Palacios; Samantha Hinsley; Celeste L. Pearce; Malcolm C. Pike; Anna M. Piskorz; Isabelle Ray-Coquard; Valerie Rhenius; Cristina Rodriguez-Antona; Raghwa Sharma; Mark E. Sherman; Dilrini De Silva; Naveena Singh; Peter Sinn; Dennis Slamon; Honglin Song; Helen Steed; Euan A. Stronach; Pamela J. Thompson; Aleksandra Tołoczko; Britton Trabert; Nadia Traficante; Chiu-Chen Tseng; Martin Widschwendter; Lynne R. Wilkens; Stacey J. Winham; Boris Winterhoff; Alicia Beeghly-Fadiel; Javier Benitez; Andrew Berchuck; James D. Brenton; Robert Brown; Jenny Chang-Claude; Georgia Chenevix-Trench; Anna deFazio; Peter A. Fasching; María J. García; Simon A. Gayther; Marc T. Goodman; Jacek Gronwald; Michelle J. Henderson; Beth Y. Karlan; Linda E. Kelemen; Usha Menon; Sandra Orsulic; Paul D.P. Pharoah; Nicolas Wentzensen; Anna H. Wu; Joellen M. Schildkraut; Mary Anne Rossing; Gottfried E. Konecny; David G. Huntsman; Ruby Yun-Ju Huang; Ellen L. Goode; Susan J. Ramus; Jennifer A. Doherty; David D. Bowtell; Michael S. Anglesio
View articletitled, Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)
Supplementary data
Open the PDF for in another window
Author Choice
Molecular Engineering of Ultrasmall Silica Nanoparticle–Drug Conjugates as Lung Cancer Therapeutics
Brian Madajewski; Feng Chen; Barney Yoo; Melik Z. Turker; Kai Ma; Li Zhang; Pei-Ming Chen; Rupa Juthani; Virginia Aragon-Sanabria; Mithat Gonen; Charles M. Rudin; Ulrich Wiesner; Michelle S. Bradbury; Cameron Brennan
View articletitled, Molecular Engineering of Ultrasmall Silica Nanoparticle–Drug Conjugates as Lung Cancer Therapeutics
Supplementary data
Open the PDF for in another window
A Radiomics Model for Predicting the Response to Bevacizumab in Brain Necrosis after Radiotherapy
Jinhua Cai; Junjiong Zheng; Jun Shen; Zhiyong Yuan; Mingwei Xie; Miaomiao Gao; Hongqi Tan; Zhongguo Liang; Xiaoming Rong; Yi Li; Honghong Li; Jingru Jiang; Huiying Zhao; Andreas A. Argyriou; Melvin L.K. Chua; Yamei Tang
View articletitled, A Radiomics Model for Predicting the Response to Bevacizumab in Brain Necrosis after Radiotherapy
Supplementary data
Open the PDF for in another window
HLA Genotyping in Synovial Sarcoma: Identifying HLA-A*02 and Its Association with Clinical Outcome
Evan Rosenbaum; Kenneth Seier; Chaitanya Bandlamudi; Mark Dickson; Mrinal Gounder; Mary L. Keohan; Ping Chi; Ciara Kelly; Sujana Movva; Benjamin Nacev; Noemi Simeone; Mark Donoghue; Emily K. Slotkin; Li-Xuan Qin; Cristina R. Antonescu; William D. Tap; Sandra P. D'Angelo
View articletitled, HLA Genotyping in Synovial Sarcoma: Identifying HLA-A*02 and Its Association with Clinical Outcome
Supplementary data
Open the PDF for in another window
PD-L1 Protein Expression on Both Tumor Cells and Macrophages are Associated with Response to Neoadjuvant Durvalumab with Chemotherapy in Triple-negative Breast Cancer
Fahad Shabbir Ahmed; Patricia Gaule; John McGuire; Katir Patel; Kim Blenman; Lajos Pusztai; David L. Rimm
View articletitled, PD-L1 Protein Expression on Both Tumor Cells and Macrophages are Associated with Response to Neoadjuvant Durvalumab with Chemotherapy in Triple-negative Breast Cancer
Supplementary data
Open the PDF for in another window

Translational Cancer Mechanisms and Therapy

A Preclinical Trial and Molecularly Annotated Patient Cohort Identify Predictive Biomarkers in Homologous Recombination–deficient Pancreatic Cancer
Yifan Wang; Jin Yong Patrick Park; Alain Pacis; Robert E. Denroche; Gun Ho Jang; Amy Zhang; Adeline Cuggia; Celine Domecq; Jean Monlong; Maria Raitses-Gurevich; Robert C. Grant; Ayelet Borgida; Spring Holter; Chani Stossel; Simeng Bu; Mehdi Masoomian; Ilinca M. Lungu; John M.S. Bartlett; Julie M. Wilson; Zu-Hua Gao; Yasser Riazalhosseini; Jamil Asselah; Nathaniel Bouganim; Tatiana Cabrera; Louis-Martin Boucher; David Valenti; James Biagi; Celia M.T. Greenwood; Paz Polak; William D. Foulkes; Talia Golan; Grainne M. O'Kane; Sandra E. Fischer; Jennifer J. Knox; Steven Gallinger; George Zogopoulos
View articletitled, A Preclinical Trial and Molecularly Annotated Patient Cohort Identify Predictive Biomarkers in Homologous Recombination–deficient Pancreatic Cancer
Supplementary data
Open the PDF for in another window
Author Choice
Evolution of Genomic and T-cell Repertoire Heterogeneity of Malignant Pleural Mesothelioma Under Dasatinib Treatment
Runzhe Chen; Won-Chul Lee; Junya Fujimoto; Jun Li; Xin Hu; Reza Mehran; David Rice; Stephen G. Swisher; Boris Sepesi; Hai T. Tran; Chi-Wan Chow; Latasha D. Little; Curtis Gumbs; Cara Haymaker; John V. Heymach; Ignacio I. Wistuba; J. Jack Lee; P. Andrew Futreal; Jianhua Zhang; Alexandre Reuben; Anne S. Tsao; Jianjun Zhang
View articletitled, Evolution of Genomic and T-cell Repertoire Heterogeneity of Malignant Pleural Mesothelioma Under Dasatinib Treatment
Supplementary data
Open the PDF for in another window
Concomitant Proton Pump Inhibitor Use and Survival in Urothelial Carcinoma Treated with Atezolizumab
Ashley M. Hopkins; Ganessan Kichenadasse; Christos S. Karapetis; Andrew Rowland; Michael J. Sorich
View articletitled, Concomitant Proton Pump Inhibitor Use and Survival in Urothelial Carcinoma Treated with Atezolizumab
Supplementary data
Open the PDF for in another window
Author Choice
Coexpression of IL7 and CCL21 Increases Efficacy of CAR-T Cells in Solid Tumors without Requiring Preconditioned Lymphodepletion
Hong Luo; Jingwen Su; Ruixin Sun; Yansha Sun; Yi Wang; Yiwei Dong; Bizhi Shi; Hua Jiang; Zonghai Li
View articletitled, Coexpression of IL7 and CCL21 Increases Efficacy of CAR-T Cells in Solid Tumors without Requiring Preconditioned Lymphodepletion
Supplementary data
Open the PDF for in another window
Evidencing a Pancreatic Ductal Adenocarcinoma Subpopulation Sensitive to the Proteasome Inhibitor Carfilzomib
Nicolas A. Fraunhoffer; Analía Meilerman Abuelafia; Martin Bigonnet; Odile Gayet; Julie Roques; Emmanuel Telle; Patricia Santofimia-Castaño; María Teresa Borrello; Eduardo Chuluyan; Nelson Dusetti; Juan Iovanna
View articletitled, Evidencing a Pancreatic Ductal Adenocarcinoma Subpopulation Sensitive to the Proteasome Inhibitor Carfilzomib
Supplementary data
Open the PDF for in another window
IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in Melanoma
Joe-Marc Chauvin; Mignane Ka; Ornella Pagliano; Carmine Menna; Quanquan Ding; Richelle DeBlasio; Cindy Sanders; Jiajie Hou; Xian-Yang Li; Soldano Ferrone; Diwakar Davar; John M. Kirkwood; Robert J. Johnston; Alan J. Korman; Mark J. Smyth; Hassane M. Zarour
View articletitled, IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in Melanoma
Supplementary data
Open the PDF for in another window
Addition of Antiestrogen Treatment in Patients with Malignant PEComa Progressing to mTOR Inhibitors
Roberta Sanfilippo; Chiara Fabbroni; Giovanni Fucà; Elena Fumagalli; Carlo Morosi; Marta Sbaraglia; Alessandro Gronchi; Paola Collini; Angelo P. Dei Tos; Paolo G. Casali
View articletitled, Addition of Antiestrogen Treatment in Patients with Malignant PEComa Progressing to mTOR Inhibitors
Supplementary data
Open the PDF for in another window

Letter to the Editor

Theranostic Targeting of CUB Domain Containing Protein 1 (CDCP1) in Pancreatic Cancer—Letter
David J. Birnbaum; Pascal Finetti; Daniel Birnbaum; François Bertucci
View articletitled, Theranostic Targeting of CUB Domain Containing Protein 1 (CDCP1) in Pancreatic Cancer—Letter
Open the PDF for in another window

Editor’s Note

Editor's Note: Overexpression of Aurora-A Contributes to Malignant Development of Human Esophageal Squamous Cell Carcinoma
Tong Tong; Yali Zhong; Jianping Kong; Lijia Dong; Yongmei Song; Ming Fu; Zhihua Liu; Mingrong Wang; Liping Guo; Shixin Lu; Ming Wu; Qimin Zhan
View articletitled, Editor's Note: Overexpression of Aurora-A Contributes to Malignant Development of Human Esophageal Squamous Cell Carcinoma
Open the PDF for in another window

Advertisement

Breaking
Tafasitamab Lowers Risk of Follicular Lymphoma Progression
9/11 First Responders Have Twofold Increase in Leukemia Precursor
Daratumumab Can Prevent Progression of Myeloma Precursor
View more recent articles
Latest News
Imlunestrant Delays Progression in Some Breast Cancers
“Digital Twins” May Improve Treatment Prediction
Prevention and Screening Preclude 80% of Cancer Deaths
View more recent articles
Research Watch
The Liver X Receptor Axis Balances Intestinal Regeneration and Tumorigenesis
Oncolytic Virotherapy Plus Nivolumab Is Safe in Muscle-Invasive Bladder Cancer
Specialized Fibroblasts Shape T-Cell Environments in Lung Cancer
View more recent articles

NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.

  • Online ISSN 1557-3265
  • Print ISSN 1078-0432

AACR Journals

 

 

  • Copyright © 2023 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept